2020
DOI: 10.33029/2304-9529-2020-9-3-71-72
|View full text |Cite
|
Sign up to set email alerts
|

Estimation of efficiency and safety of use SGLT2 inhibitors and glucagon-like peptide agonists among patients with diabetes and cardiovascular disease in clinical practice

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles